Growth Metrics

Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2026)

Vivos Therapeutics (VVOS) reported Prepaid Assets of $940000.0 for Q1 2026, up 71.85% year-over-year from $547000.0 in Q1 2025, and up 21.45% on a QoQ basis from $774000.0 in Q4 2025.

Vivos Therapeutics (VVOS) has 8 years of Prepaid Assets data on file, last reported at $940000.0 in Q1 2026.

  • Quarterly Prepaid Assets rose 71.85% year-over-year to $940000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $940000.0 (up 71.85% YoY) and the FY2025 annual result came in at $774000.0, down 1.15% from the prior year.
  • Prepaid Assets advanced to $940000.0 in Q1 2026 per VVOS's latest filing, from $774000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.3 million in Q1 2022 and bottomed at $475000.0 in Q1 2024.
  • The 5-year median for Prepaid Assets is $774000.0 (2025), against an average of $1.0 million.
  • The widest annual swing landed in 2022, when Prepaid Assets surged 143.09%; it then sank 64.71% in 2024.
  • Tracing VVOS's Prepaid Assets over 5 years: stood at $1.4 million in 2022, then slumped by 57.46% to $616000.0 in 2023, then climbed by 27.11% to $783000.0 in 2024, then fell by 1.15% to $774000.0 in 2025, then climbed by 21.45% to $940000.0 in 2026.
  • Per Business Quant, the three latest VVOS Prepaid Assets figures stand at $940000.0 (Q1 2026), $774000.0 (Q4 2025), and $565000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vivos Therapeutics 9.87 Mn 7.64 Mn 3.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 940,000.00
Dec 31, 2025 774,000.00
Sep 30, 2025 565,000.00
Jun 30, 2025 695,000.00
Mar 31, 2025 547,000.00
Dec 31, 2024 783,000.00
Sep 30, 2024 634,000.00
Jun 30, 2024 554,000.00
Mar 31, 2024 475,000.00
Dec 31, 2023 616,000.00
Sep 30, 2023 769,000.00
Jun 30, 2023 1.07 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 1.45 Mn
Sep 30, 2022 2.12 Mn
Jun 30, 2022 2.06 Mn
Mar 31, 2022 2.26 Mn
Dec 31, 2021 1.58 Mn
Sep 30, 2021 1.60 Mn
Jun 30, 2021 1.67 Mn
Mar 31, 2021 927,627.00
Dec 31, 2020 673,000.00
Dec 31, 2019 295,002.00